HPS0249 疾患特異的iPS細胞株。筋萎縮性側索硬化症患者由来。エピソーマルベクターによりヒト6因子（Oct3/4, Sox2, Klf4, L-Myc, Lin28, p53に対するshRNA）を導入して樹立。<a href='https://cell.brc.riken.jp/ja/manual/vitrification' target="_blank">ガラス化法（Vitrification法）</a>保存。 HPS0249 1) 非営利の団体に所属する利用者による学術研究に限る。 2) 寄託者から承諾を得ること。 3) 成果の公表にあたって謝辞の表明を必要とする。 4) 先ずは、<a href="mailto:cellips.brc@riken.jp?subject=Disease specific iPS cell line 問い合わせ&amp;">理研細胞バンク</a>にお問い合わせください 。 1) The BIOLOGICAL RESOURCE must be used for academic research purpose conducted by RECIPIENT who belongs to a not-for profit academic organization (i.e. a university or another institution of higher education or any non-profit scientific or educational organization, including government agencies) . 2) The RECIPIENT agrees to obtain the prior written approval of the distribution from the APPROVER. 3) In publishing the research results to be obtained by use of the BIOLOGICAL RESOURCE, an acknowledgment to the DEPOSITOR is requested. 4) Contact Us : <a href="mailto:cellips.brc@riken.jp?subject=Disease specific iPS cell line&amp;">RIKEN Cell Bank</a> Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). 疾患特異的iPS細胞株。筋萎縮性側索硬化症患者由来。エピソーマルベクターによりヒト6因子（Oct3/4, Sox2, Klf4, L-Myc, Lin28, p53に対するshRNA）を導入して樹立。<a href='http://cell.brc.riken.jp/ja/manual/vitrification' target="_blank">ガラス化法（Vitrification法）</a>保存。 Disease specific iPS cell line derived from a patient : Amyotrophic lateral sclerosis (ALS). Order Form (C-0042, C-0057, C-0007).